Cargando…

Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?

OBJECTIVES: The present study was conducted to estimate the seroprevalence of antibody to pertussis toxin among adult populations in western Saudi Arabia. DESIGN: A cross-sectional study. SETTING: King Abdulaziz Medical City, Jeddah, western Saudi Arabia. A tertiary care teaching hospital. PARTICIPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Farahat, Fayssal, Althaqafi, Abdulhakeem, Al-Amri, Abdulfattah, Alsaedi, Asim, Abouremsh, Mohammad, Alshamrani, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039228/
http://dx.doi.org/10.1136/bmjopen-2020-042711
_version_ 1783677544478801920
author Farahat, Fayssal
Althaqafi, Abdulhakeem
Al-Amri, Abdulfattah
Alsaedi, Asim
Abouremsh, Mohammad
Alshamrani, Majid
author_facet Farahat, Fayssal
Althaqafi, Abdulhakeem
Al-Amri, Abdulfattah
Alsaedi, Asim
Abouremsh, Mohammad
Alshamrani, Majid
author_sort Farahat, Fayssal
collection PubMed
description OBJECTIVES: The present study was conducted to estimate the seroprevalence of antibody to pertussis toxin among adult populations in western Saudi Arabia. DESIGN: A cross-sectional study. SETTING: King Abdulaziz Medical City, Jeddah, western Saudi Arabia. A tertiary care teaching hospital. PARTICIPANTS: A total of 1200 participants (400 healthcare workers, 400 military recruits and 400 blood donors) were included. The majority were male (79.3%), and the mean (±SD) age was 27.2 (±6.7) years old. INTERVENTIONS: The study included the analysis of serum blood samples using commercial ELISA. A consecutive sampling technique was applied. PRIMARY OUTCOME MEASURES: Seropositivity of antipertussis toxin immunoglobulin G (anti-PT IgG) ≥62.5 IU/mL. RESULTS: Antibody titres ≥62.5 IU/mL, indicating exposure to Bordetella pertussis infection within the last year, were identified in 12.0% (95% CI 10.2% to 14.0%) of the participants. Titres ≥125 IU/mL, suggesting recent infection, were detected in 3.5% (95% CI 2.5% to 4.7%). Seroprevalence of positive IgG antibody titres (≥62.5 IU/mL) was highest among the healthcare workers (HCWs) (14%), then the military recruits (13.5%) and blood donors (8.5%; p=0.03). The multivariate regression analysis showed association between participants group (HCWs and military), male gender and younger age (<25 years old) and higher antibody to pertussis toxin. CONCLUSIONS: High pertussis seropositivity was associated with participants’ occupation (ie, healthcare workers and military recruits), and anti-PT IgG titre was negatively correlated with age. A substantial deficiency in pertussis reporting in Saudi Arabia has been suggested, with potential increased risk to the most vulnerable populations (ie, infants and elderly). Enhancing the booster dose of pertussis vaccine for adolescents and adults is crucial to minimise the burden of pertussis.
format Online
Article
Text
id pubmed-8039228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-80392282021-04-26 Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults? Farahat, Fayssal Althaqafi, Abdulhakeem Al-Amri, Abdulfattah Alsaedi, Asim Abouremsh, Mohammad Alshamrani, Majid BMJ Open Epidemiology OBJECTIVES: The present study was conducted to estimate the seroprevalence of antibody to pertussis toxin among adult populations in western Saudi Arabia. DESIGN: A cross-sectional study. SETTING: King Abdulaziz Medical City, Jeddah, western Saudi Arabia. A tertiary care teaching hospital. PARTICIPANTS: A total of 1200 participants (400 healthcare workers, 400 military recruits and 400 blood donors) were included. The majority were male (79.3%), and the mean (±SD) age was 27.2 (±6.7) years old. INTERVENTIONS: The study included the analysis of serum blood samples using commercial ELISA. A consecutive sampling technique was applied. PRIMARY OUTCOME MEASURES: Seropositivity of antipertussis toxin immunoglobulin G (anti-PT IgG) ≥62.5 IU/mL. RESULTS: Antibody titres ≥62.5 IU/mL, indicating exposure to Bordetella pertussis infection within the last year, were identified in 12.0% (95% CI 10.2% to 14.0%) of the participants. Titres ≥125 IU/mL, suggesting recent infection, were detected in 3.5% (95% CI 2.5% to 4.7%). Seroprevalence of positive IgG antibody titres (≥62.5 IU/mL) was highest among the healthcare workers (HCWs) (14%), then the military recruits (13.5%) and blood donors (8.5%; p=0.03). The multivariate regression analysis showed association between participants group (HCWs and military), male gender and younger age (<25 years old) and higher antibody to pertussis toxin. CONCLUSIONS: High pertussis seropositivity was associated with participants’ occupation (ie, healthcare workers and military recruits), and anti-PT IgG titre was negatively correlated with age. A substantial deficiency in pertussis reporting in Saudi Arabia has been suggested, with potential increased risk to the most vulnerable populations (ie, infants and elderly). Enhancing the booster dose of pertussis vaccine for adolescents and adults is crucial to minimise the burden of pertussis. BMJ Publishing Group 2021-04-08 /pmc/articles/PMC8039228/ http://dx.doi.org/10.1136/bmjopen-2020-042711 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Farahat, Fayssal
Althaqafi, Abdulhakeem
Al-Amri, Abdulfattah
Alsaedi, Asim
Abouremsh, Mohammad
Alshamrani, Majid
Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
title Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
title_full Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
title_fullStr Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
title_full_unstemmed Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
title_short Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
title_sort cross-sectional seroprevalence study of antibody to bordetella pertussis toxin in western saudi arabia: is there a need for a vaccine booster dose for adolescents and young adults?
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039228/
http://dx.doi.org/10.1136/bmjopen-2020-042711
work_keys_str_mv AT farahatfayssal crosssectionalseroprevalencestudyofantibodytobordetellapertussistoxininwesternsaudiarabiaisthereaneedforavaccineboosterdoseforadolescentsandyoungadults
AT althaqafiabdulhakeem crosssectionalseroprevalencestudyofantibodytobordetellapertussistoxininwesternsaudiarabiaisthereaneedforavaccineboosterdoseforadolescentsandyoungadults
AT alamriabdulfattah crosssectionalseroprevalencestudyofantibodytobordetellapertussistoxininwesternsaudiarabiaisthereaneedforavaccineboosterdoseforadolescentsandyoungadults
AT alsaediasim crosssectionalseroprevalencestudyofantibodytobordetellapertussistoxininwesternsaudiarabiaisthereaneedforavaccineboosterdoseforadolescentsandyoungadults
AT abouremshmohammad crosssectionalseroprevalencestudyofantibodytobordetellapertussistoxininwesternsaudiarabiaisthereaneedforavaccineboosterdoseforadolescentsandyoungadults
AT alshamranimajid crosssectionalseroprevalencestudyofantibodytobordetellapertussistoxininwesternsaudiarabiaisthereaneedforavaccineboosterdoseforadolescentsandyoungadults